Company / Net Income
Apogee Therapeutics, Inc. Net Income History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$182.1M
FY2024
5-year range
-$182.1M / -$39.8M
FY2022-FY2024
Trend
-116.9%
vs FY2023
Sector context
#149 of 216
Health Care
What the data says
At -$182M, Apogee Therapeutics, Inc.'s net income ranks #149 of 216 in the Health Care sector. Declined from -$40M to -$182M over the past 2 years.
Based on SEC 10-K filings.
-$182M in FY2024.
Declined from -$40M to -$182M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#149 of 216 in Health CareTop 69% of 216This company -$182.1M Sector average $454.3M
▼
-140.1% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 116.9% year-over-year.
- Ranks #149 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$182.1M | -116.9% |
| FY2023 | -$84.0M | -111.1% |
| FY2022 | -$39.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026